Hellman Jordan Management CO Inc Magenta Therapeutics, Inc. Transaction History

Hellman Jordan Management CO Inc

$58.9 Million
Q4 2022

A detailed history of Hellman Jordan Management CO Inc transactions in Magenta Therapeutics, Inc. stock. As of the latest transaction made, Hellman Jordan Management CO Inc holds 441,125 shares of MGTA stock, worth $0. This represents 0.3% of its overall portfolio holdings.

Number of Shares

441,125

Previous 181,964 142.42%

Holding current value

Previous $257,000 32.3%

% of portfolio

0.3%

Previous 0.45%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$0.36 - $1.59 $93,297 - $412,065	259,161 Added 142.42%	441,125 $174,000
Q3 2022 Oct 13, 2022	SELL	$1.26 - $2.09 $142,425 - $236,245	-113,036 Reduced 38.32%	181,964 $257,000
Q2 2022 Sep 27, 2022	BUY	$0.97 - $3.08 $286,150 - $908,600	295,000 New	295,000 $354,000

Others Institutions Holding MGTA

# of Institutions

Shares Held

442K

Call Options Held

Put Options Held

Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.3K
Shares

$0
0.0% of portfolio

View Full List

About Magenta Therapeutics, Inc.

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

More about MGTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hellman Jordan Management CO Inc with notifications on news.

Account

Hellman Jordan Management CO Inc Magenta Therapeutics, Inc. Transaction History